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The purpose of the present study was to examine the proﬁle of selected proinﬂammatory cytokines in maternal serum of ﬁrst-
trimester pregnancies complicated by threatened abortion (TACP) and its relevance to obstetric outcome. Serum levels of Th1-
type cytokines interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-alpha), and Th2-type cytokine interleukin 6 (IL-6) were
measured, by ELISA, in 22 women with TACP and adverse outcome at admission (group A) and compared with the corresponding
levels of 31 gestational age-matched women with TACP and successful outcome at admission (group B1) and discharge (group
B2) and 22 gestational age-matched women with ﬁrst-trimester uncomplicated pregnancy (group C) who served as controls.
Mann-Whitney U or Wilcoxon test was applied as appropriate to compare diﬀerences between groups. IL-1β and TNF-alpha were
detected with signiﬁcantly higher levels in group A, compared to all other groups. On the contrary, IL-6 levels were detected with
no signiﬁcant diﬀerence among all the other groups studied. It is concluded that in ﬁrst-trimester TACP with adverse outcome, a
distinct immune response, as reﬂected by elevated maternal IL-1β, TNF-alpha, and unaltered IL-6 levels, is relevant to a negative
obstetric outcome.
Copyright © 2006 Nicolaos Vitoratos et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Spontaneous abortion is the loss of an intrauterine preg-
nancy without outside intervention before 20 weeks’ gesta-
tion and can be subdivided into threatened abortion, in-
evitable abortion, incomplete abortion, missed abortion,
septic abortion, complete abortion, and recurrent sponta-
neous abortion [1]. Threatened abortion refers to an in-
trauterine viable clinical pregnancy accompanied by an in-
trauterine source of painless vaginal bleeding and successful
or adverse pregnancy outcome [2].
The cytokine network has been suggested to be involved
with positive or negative evolution of the ongoing pregnan-
cies [3]. Prevalence of Th2-type cytokines (secreted by T-
helper 2 cells and certain antigen-presenting cells (APCs))
may be associated with successful pregnancy; whereas the
dominance of Th1-type cytokines (derived from T-helper 1
cells and APCs) may be indicative of a pathological preg-
nancy both in experimental animals and in humans [4, 5].
IL-1β is an essential proinﬂammatory, Th1-type cy-
tokine, produced by monocytes, macrophages, and epithelial
cells. Its secretion leads to production of tumor necro-
sis factor (TNF-alpha), interferon (IFN-γ), IL-2, and IL-
12 [6], uterotonic prostaglandin E2 and/or matrix metal-
loproteinases by fetal membrane cells, as well as to pro-
motion of apoptotic cell death in fetal membrane tissues
[7]. Due to these properties, IL-1β may express abortogenic
action. On the other side, elevated IL-1β levels may in-
crease the likelihood of successful and complete implanta-
tion, and, during the ﬁrst trimester, may also oﬀer the fe-
tus increased protection against microbial pathogens that
were present in the uterus before the conception period, dur-
ing the conception period, or in the early postconception
period [8].
TNF-alpha, a Th1-type cytokine, is mainly produced by
mononuclear phagocytes, natural killer cells, and antigen-
stimulated T-cells. Similarly to IL-1β, TNF-alpha promotes
apoptotic cell death in fetal membrane tissues [7]a n da c -
tivates coagulation via upregulating the novel prothrombi-
nase, fgl2 [9]. The proinﬂammatory, proapoptotic, and pro-
coagulant properties of TNF-alpha probably contribute to
the widely accepted abortogenic proﬁle of this cytokine.2 Mediators of Inﬂammation
IL-6 is a multifunctional Th2-type cytokine produced by
immune cells, ﬁbroblasts, endothelial cells, adipocytes, and
myocytes [10].TheroleofIL-6expressionduringpregnancy,
as well as its predictive value for pregnancy outcome, is un-
clear, although it generally seems to favor pregnancy suc-
cess [10]. IL-6 is considered to be a proinﬂammatory cy-
tokine. Elevated levels of IL-6 in the placenta, amniotic cells,
a n dd e c i d u a sh a v eb e e nd e m o n s t r a t e di np r e g n a n c i e sc o m -
plicated by preterm premature rupture of the membranes,
intrauterine infection, and prematurity [11]. However, IL-6
also has antiinﬂammatory properties. In this context, IL-6
hasbeenshowntoinducethereleaseofhumanchorionicgo-
nadotrophin from trophoblasts, leading to a subsequent cas-
cade of progesterone production, release of Th2 cytokines,
for example, IL-4, and suppression of Th1 cytokines [12].
To our knowledge, there are no reports on maternal
serum IL-1β levels and a limited number of reports explor-
ing the proﬁle of TNF-alpha [13] and IL-6 [2]l e v e l si n
ﬁrst-trimester threatened abortion-complicated pregnancies
(TACP), and, moreover, there are no reports evaluating the
relevanceofmaternalserumlevelsofallthesethreecytokines
to adverse obstetric outcome. By investigating the proﬁle of
IL-1β, TNF-alpha, and IL-6 levels in maternal serum of ﬁrst-
trimester TACP with adverse and successful outcome and of
uncomplicated pregnancies, the present study intended to
clarify whether an imbalance between selected Th1-type and
Th2-type cytokines reﬂecting a Th1/Th2 ratio shift in ﬁrst-
trimesterTACPhasanyrelevancetothesubsequentobstetric
outcome.
MATERIAL AND METHODS
Studydesign
This is a prospective, nonrandomized, case-control clinical
studyconductedinauniversity-basedmaternityhospitaland
a university-based hormone and research laboratory.
Participants
Seventy-ﬁvenulliparouswomeninﬁrst-trimesterpregnancy,
who presented in the 2nd Academic Department of Obstet-
rics and Gynecology, Aretaieion Hospital, were enrolled in
the study. The gestational age of all women, based on ul-
trasound measurements, ranged between the 7th and 10th
weeks. Fifty-three of them were admitted with the indica-
tion of threatened abortion, as deﬁned by the presence of
vaginal bleeding [light (deﬁned as spotting only) or heavy],
closed cervical os, and viable fetus with positive heart ac-
tivity detected by ultrasonographic examination. All these
women were hospitalized, and their management included
bed rest and pregnancy well-being evaluation with β-human
chorionic gonadotropin evaluation and ultrasound assess-
ment. Thirty-one out of 53 women with threatened abor-
tion (group A) were discharged after resolution of vaginal
bleeding and U/S conﬁrmation of a viable fetus. Twenty-two
(group B) out of 53 women with threatened abortion sub-
sequently presented profound bleeding and expulsion of the
embryos or clinical and ultrasonographic signs of nonviable
pregnancy after 7–12 days from admission. The women of
this group underwent evacuation of the products of concep-
tion under general anesthesia. The rest 22 out of 75 women
of the same gestational age range were asymptomatic and
r e c r u i t e da sc o n t r o l s( g r o u pC ) .E x c l u s i o nc r i t e r i aw e r ea s
follows: (1) subjects’ age > 35 years, (2) previous history
of subfertility, (3) previous abortion, (4) remarkable previ-
ous medical, surgical and gynecological history, (5) smoking
or alcohol habits and medication intake. The study was ap-
proved by the Institutional Ethics Committee of Aretaieion
Hospital, and informed consent was obtained from all sub-
jects prior to participation.
Analyticalmethods
Venous blood samples were collected once (on admission)
from women of groups B and C, and twice (on admission
and discharge) from women of group A, into 10 mL ster-
ile tubes without anticoagulant before administration of any
medication. All sera were stored at −75◦C until analysis.
Serum concentrations of IL-1β were assessed, in dubli-
cate, by a high sensitivity ELISA kit (HSLB50, RnD Systems
Europe, Ltd, Abingdon, UK). The range of measurement
was 0.125–8 pg/mL, the intra- and interassay coeﬃcients of
variation were 10.2% and 19.2%, respectively, and the an-
alytical sensitivity was 0.1 pg/mL. Serum concentrations of
TNF-alpha were estimated, in dublicate, by a high sensitiv-
ity ELISA kit (HSTA00C, RnD Systems Europe, Ltd, Abing-
don, UK). The range of measurement was 0.5–32 pg/mL,
the inta- and inter-assay coeﬃcients of variation were 8.8%
and 12.6%, respectively, and the analytical sensitivity was
0.12 pg/mL. Serum concentrations of IL-6 were assessed, in
dublicate, by a high sensitivity ELISA kit (HSLB50, RnD Sys-
tems Europe, Ltd, Abingdon, UK). The range of measure-
ment was 0.156–10 pg/mL, the intra- and interassay coeﬃ-
cients of variation were 7.8% and 9.2%, respectively, and the
analytical sensitivity was 0.04 pg/mL.
Distribution of IL-1β, IL-6, and TNF-alpha concentra-
tions were tested for normality with the use of the Shapiro-
Wilk test, and the hypothesis that they are normally dis-
tributed was rejected. Statistically signiﬁcant diﬀerences of
median values between groups were calculated using Mann-
Whitney U test (unpaired diﬀerences) or Wilcoxon test
(paired diﬀerences) and P-values for median values less than
.05 were considered as signiﬁcant. The results are expressed
as median (range). The statistical package SPSS 8.0 (Statisti-
cal Package for the Social Sciences, SPSS Inc., Chicago) was
used.
RESULTS
Median age was similar among all the studied groups: 30.4
(range 21–34) years in group A, 27.2 (range 22–34) years in
group B, and 27.3 (range 22–34) years in group C, (P = .34).
Similarly, median gestational age did not diﬀer among all the
studied groups: 8.5 (range 8–10) weeks in group A on ad-
mission, 8.7 (range 8.1–10) weeks in group B, and 8.2 (range
8–9.8) weeks in group C, (P = .20). The median gestational
age of group A on discharge was 9.6 (range 8.5–10.5)Nicolaos Vitoratos et al 3
Table 1: Maternal serum levels of IL-1β, IL-6, and TNF-alpha in the study population [values are medians (range)].
GROUP A GROUP B GROUP C
On admission On discharge
IL-1β (pg/mL) 0.23(0.14–1.00) 0.25(0.14–0.99) 0.43(0.20–1.13) 0.20(0.14–1.16)
TNF-alpha (pg/mL) 2.93(1.40–24.30) 2.48(1.00–23.70) 7.81(4.34–26.30) 4.27(1.56–22.12)
IL-6 (pg/mL) 1.97(0.13–8.00) 1.76(0.27–8.00) 1.82(0.52–8.00) 2.51(0.24–9.60)
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Figure 1: Serum levels (median, SEM) of IL-1β in the three study
groups.
Table 1 shows the serum levels of IL-1β,I L - 6 ,a n dT N F -
alpha in Group A (on admission and on discharge) as well as
in Groups B and C (on admission/presentation).
In Group A, IL-1β, IL-6, and TNF-alpha values on ad-
mission were comparable to those on discharge (P = .9, .12,
and .06, resp) as well as to those found in group C (.55, .73,
and .07, resp).
AdmissionserumvaluesofIL-1βinGroupBweresigniﬁ-
cantlyhigherwhencomparedtothoseinGroupA(P = .001)
as well as to those in group C (P = .001) (Figure 1).
Furthermore, admission serum values of TNF-alpha in
GroupBweresigniﬁcantlyhigherwhencomparedtothosein
Group A (P<. 001) as well as to those in Group C (P<. 001)
(Figure 2).
Finally, the IL-6 levels were comparable among the three
groups (Group A versus Group B: P = .55, Group A versus
Group C: P = .73, and Group B versus Group C: P = .33)
(Figure 3).
DISCUSSION
The data of this study demonstrate that (a) maternal IL-
1β and TNF-alpha levels are higher in ﬁrst-trimester TCAP
with adverse outcome than in ﬁrst-trimester TCAP with suc-
cessful outcome, both at admission and discharge, and ﬁrst-
trimester uncomplicated pregnancy; (b) maternal IL-6 levels
in ﬁrst-trimester TCAP with adverse outcome are compara-
ble to those in ﬁrst-trimester TCAP with successful outcome,
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Figure 2: Serum levels (median, SEM) of TNF-alpha in the three
study groups.
both at admission and discharge, as well as those in ﬁrst-
trimester uncomplicated pregnancy; (c) maternal all IL-1β,
TNF-alpha, and IL-6 levels are also similar in ﬁrst-trimester
TCAP with successful outcome, both at admission and dis-
charge, and in ﬁrst-trimester uncomplicated pregnancy.
Cytokines, as critical immunoregulatory molecules, re-
sponsiblefordeterminingthenatureofanimmuneresponse,
have been shown to inﬂuence all steps of reproduction, play-
ing a fundamental role in pregnancy outcome.
As a Th1-type proinﬂammatory cytokine, IL-1β may
inﬂuence Th1/Th2 immune responsiveness, thus implicat-
ing in the establishment of successful pregnancy. Although
known to alter IL-1β expression, IL-1β gene functional poly-
morphisms are not associated to recurrent miscarriage [14].
Similar serum levels of IL-1β have been reported in a large
Caucasian population of women with a history of three or
moreconsecutivepregnancylossesbefore20weeks’gestation
in comparison to those of healthy women with at least two
live births and no history of pregnancy loss [15]. Elevated
IL-1β serum levels were reported in ﬁrst-trimester pregnant
womenwhopresentedwithinevitableabortionandahistory
of at least 3 prior spontaneous consecutive abortions, this
in comparison to ﬁrst-trimester pregnant women presenting
with their ﬁrst miscarriage due to chromosomal anomalies
[16]. IL-1β serum levels in ﬁrst-trimester TACP have never
been evaluated. In the present study, IL-1β levels in mater-
nal serum of ﬁrst trimester threatened aborters who eventu-
allymiscarriedweresigniﬁcantlyhigherthanthoseofwomen4 Mediators of Inﬂammation
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Figure 3: Serum levels (median, SEM) of IL-6 in the three study
groups.
withﬁrst-trimesteruncomplicatedpregnancy.Thus,elevated
IL-1β levels in ﬁrst-trimester TACP should not be considered
as a compensatory or protective physiological response, but,
instead, may probably indicate cytokine-induced detrimen-
tal eﬀects on pregnancy continuation. Moreover, maternal
IL-1β serum levels in ﬁrst-trimester TACP with poor out-
come were signiﬁcantly higher than those in ﬁrst-trimester
TACP with good outcome, both at admission and discharge.
TNF-alpha is a proinﬂammatory, proapoptotic, and pro-
coagulantand,thus,abortogenic,mainlyTh1-type,cytokine.
Its production is also partly under genetic control. Contra-
dictory data report that TNF-alpha functional gene poly-
morphisms are not correlated with recurrent spontaneous
abortion (RSA) in Caucasians [17] show a trend to be as-
sociated with RSA [18], or associated with an increased risk
for RSA [19]. In pregnant women at <20 weeks of gesta-
tional age and with a history of RSA, several reports agree
that serum TNF-alpha levels are elevated in comparison to
those of healthy pregnant women at the same gestational age
[20, 21]. More importantly, two studies report increased or
unalteredTNF-alphaproductioninperipheralbloodofnon-
pregnant women with a history of RSA, when blood was cul-
tivated in the presence of phytohemagglutinine (PHA) [21]
or trophoblast cells [4]. Contradictory data report decreased
[22] or increased [23] TNF-alpha levels in or at onset of
spontaneous abortion, respectively, in comparison to nor-
mal pregnancies. TNF-alpha levels similar to those in nor-
mal pregnancy were reported in threatened abortion with a
good outcome [13]. There are no studies evaluating TNF-
alphalevelsinﬁrst-trimesterTACPwithanadverseoutcome.
In the present study, the elevated maternal TNF-alpha levels
in ﬁrst-trimester TACP with a poor outcome, in compari-
son to those of uncomplicated pregnancy and TACP with a
good outcome, further support the abortogenic role of this
cytokine. Moreover, resembling maternal IL-1β levels, ma-
ternal TNF-alpha levels were higher in ﬁrst-trimester TACP
with poor outcome than in ﬁrst-trimester TACP with good
outcome, both at admission and discharge. This result, to-
gether with the corresponding result noticed in IL-1β levels,
further supports the concept that ﬁrst-trimester TACP with
adverse outcome may be an immunologically diﬀerent en-
tity, at least compared to the ﬁrst-trimester TACP with good
outcome. Furthermore, all these combined results indicate
the relevance of the elevated Th1-type cytokines IL-1β and
TNF-alpha to an adverse obstetric outcome in TACP.
IL-6 is a Th2-type, pro- as well as antiinﬂammatory cy-
tokine. Because of its properties, IL-6 has been extensively
proposed to counterbalance detrimental eﬀects of Th1-type
cytokines [2]. IL-6 production is also partially determined
by cytokine genotyping. Contradictory data report diﬀerent
functional gene polymorphisms of IL-6 to be well [24]o r
not [17] associated with the pathogenesis of RSA or even
to decrease the risk for RSA [25]. No signiﬁcant diﬀer-
ences in circulating IL-6 levels were reported for pregnant
women at <20 weeks of gestation with RSA, in compari-
son to nonpregnant women with a past history of habit-
u a la b o r t i o na sw e l la sh e a l t h yn o n p r e g n a n tw o m e n[ 20].
Moreover, lipopolysaccharide-stimulated IL-6 production in
peripheral blood of nonpregnant women with RSA and, at
least, three consecutive spontaneous abortions was similar
to that of women with a history of successful pregnancies
and no miscarriage [26]. Recently, unaltered maternal serum
IL-6 levels are reported in women with threatened abortion
compared to those of normal pregnant and nonpregnant
women; whereas signiﬁcantly lower values were observed in
women with missed abortion [2]. In the present study, ma-
ternal serum IL-6 levels in ﬁrst-trimester TACP with ad-
verseoutcomewereunalteredincomparisontothoseofﬁrst-
trimester healthy pregnant women. This result grossly agrees
with that previously reported data [2]; however, for the ﬁrst
time, it distinguishes between positive and negative obstetric
outcome of ﬁrst-trimester TACP. Similarly, maternal serum
IL-6 levels in ﬁrst-trimester TACP with adverse outcome
werefoundtobecomparabletothoseofﬁrst-trimesterTACP
with good outcome, both at admission and discharge. These
resultstogethersuggestthatalthoughthereisnotanyTh2de-
ﬁciency in ﬁrst-trimester TACP, however, an increased Th1-
typeimmuneresponsecannotbecounterbalancedbytheun-
altered Th2-type immune response, thus resulting in nega-
tive obstetric outcome. Further more, this result emphasizes
that, in ﬁrst-trimester TACP with adverse outcome, the shift
in Th1/Th2 ratio is attributed only to the increase of Th1-
type immune response and not to the simultaneous decrease
of Th2-type immune response, as it has been proposed for
other types of spontaneous abortion [2]. In this context, this
shift represents a distinct Th1/Th2 ratio pattern strengthen-
ing the concept of the distinct immune response proﬁle in
ﬁrst-trimester TACP.
Inthepresentstudy,nodiﬀerenceswerenoticedinIL-1β,
TNF-alpha,andIL-6levelsofﬁrst-trimesterTACPwithgood
outcomebetweenadmissionanddischarge.Thisresult,inac-
cordance with other previously published data for IL-6 levels
[2], suggest that among threatened aborters matched for the
severity of vaginal bleeding, subsequent obstetric outcome is
determined by the type of immune response rather than byNicolaos Vitoratos et al 5
remission of symptoms (vaginal bleeding). Finally, in accor-
dance with previously reported data, at least for TNF-alpha
[13], no diﬀerences were noticed in all maternal serum IL-
1β, TNF-alpha, and IL-6 levels between ﬁrst-trimester TACP
with good outcome, both at admission and discharge, and
ﬁrst-trimester uncomplicated pregnancy. This result further
emphasizes that in ﬁrst-trimester TACP with good outcome,
the Th1/Th2 ratio, as reﬂected by the selected cytokines, re-
sembles this one of healthy pregnancy. Thus, ﬁrst-trimester
TACP with good outcome is immunologically similar to a
ﬁrst-trimester uncomplicated pregnancy.
A shortcoming of this study might be that control groups
with nonpregnant women with a past history of threatened
abortionandadverseorsuccessfuloutcomeandhealthynon-
pregnant women were not included. Although this does not
alter the main ﬁnding of the study, comparisons with these
groups could add information to the emerging concept of a
distinguished immune response in ﬁrst-trimester TACP with
an adverse outcome. In addition, functional polymorphisms
o fT N F - a l p h aa n dI L - 6g e n e sa sw e l la sf e t a lc h r o m o s o m a l
karyotype of abortive tissue [27], both proposed to partly in-
ﬂuence respective cytokine levels were not evaluated in this
study.However,itwasimpossibletoevaluateallthesegenetic
proﬁle parameters in the limits of a single study.
In conclusion, ﬁrst-trimester TACP with positive obstet-
ric outcome is immunologically similar to a ﬁrst-trimester
uncomplicated pregnancy. On the contrary, a ﬁrst-trimester
TACP with adverse outcome represents an immunologically
distinct entity of spontaneous abortion. This distinct im-
mune response, characterized by elevated maternal IL-1β
and TNF-alpha and unaltered IL-6 levels, when compared
to ﬁrst-trimester uncomplicated pregnancy and TACP with
a good outcome, results in a shift of Th1/Th2 ratio that is
relevanttoanadverseobstetricoutcome.Furtherprospective
studiesincludingalargenumberofﬁrst-trimesterthreatened
aborters with good and bad obstetric outcome and an exten-
sive multivariable logistic regression analysis are required to
clarify if this distinct type of immune response can be also
rationalized as a negative predictor of the obstetric outcome.
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